Methods for treating cognitive impairment and improving cognition

Details for Australian Patent Application No. 2004251596 (hide)

Owner Cognition Pharmaceuticals LLC

Inventors Wiig, Kjesten A.; Zarevics, Peter; Carpenter, Randall L.; Arnold, H. Moore; Epstein, Mel H.

Agent Davies Collison Cave

Pub. Number AU-B-2004251596

PCT Pub. Number WO2005/000203

Priority 10/444,970 23.05.03 US; 10/791,223 02.03.04 US; 60/473,168 23.05.03 US

Filing date 21 May 2004

Wipo publication date 6 January 2005

Acceptance publication date 17 April 2008

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000203 Priority application(s): WO2005/000203

16 March 2006 Amendment Made

  The nature of the amendment is: Add coinventor Zarevics, Peter

10 August 2006 Assignment before Grant

  Sention, Inc. The application has been assigned to Cognition Pharmaceuticals LLC

22 March 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Carpenter, Randall C to Carpenter, Randall L

17 April 2008 Application Accepted

  Published as AU-B-2004251596

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251598-Pancreatic cancer treatment

2004251578-Method and equipment for continuous or semicontinuous casting of metal